54.174.225.82
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Sarcoma

Immix Doses First Patient in USA in its Phase 1b/2a Trial in Patients with Advanced Solid Tumors

Immix Biopharma, Inc., announced today that the first patient in the USA was dosed successfully in its flagship phase 1b/2a clinical trial testing Imx-110 in patients with refractory solid tumors. To-date, the trial has accrued patients across tumor types. The expansion of the study to the US builds upon Immix' results from Australia, wherein six...

Read More
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-